110 related articles for article (PubMed ID: 9712295)
1. The 20210A allele of the prothrombin gene is not a risk factor for retinal vein occlusion.
Delahousse B; Arsène S; Piquemal R; Iochmann S; Le Lez ML; Pouplard C; Gruel Y
Blood Coagul Fibrinolysis; 1998 Jul; 9(5):447-8. PubMed ID: 9712295
[No Abstract] [Full Text] [Related]
2. The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study.
Incorvaia C; Parmeggiani F; Costagliola C; Lamberti G; Ferraresi P; Bernardi F; Sebastiani A
Graefes Arch Clin Exp Ophthalmol; 2001 Apr; 239(4):251-6. PubMed ID: 11450488
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
[TBL] [Abstract][Full Text] [Related]
4. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.
Larsson J; Hillarp A
Thromb Res; 1999 Nov; 96(4):323-7. PubMed ID: 10593436
[TBL] [Abstract][Full Text] [Related]
5. Retinal vein occlusion, the contraceptive pill and the prothrombin 20210A allele.
Edwards M; Longstaff S; Makris M
Eye (Lond); 1999 Apr; 13 ( Pt 2)():269. PubMed ID: 10450401
[No Abstract] [Full Text] [Related]
6. Prothrombin 20210A mutation in acute posterior cerebral artery infarction and branch retinal vein occlusion.
Rachapudi SS; Charoenkijkajorn C; Pakravan M; Lee AG
Can J Ophthalmol; 2023 Dec; 58(6):e259-e262. PubMed ID: 37545047
[No Abstract] [Full Text] [Related]
7. Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion.
Weger M; Renner W; Pinter O; Stanger O; Temmel W; Fellner P; Schmut O; Haas A
Eye (Lond); 2003 Aug; 17(6):731-4. PubMed ID: 12928685
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype.
Incorvaia C; Lamberti G; Parmeggiani F; Ferraresi P; Calzolari E; Bernardi F; Sebastiani A
Am J Ophthalmol; 1999 Aug; 128(2):247-8. PubMed ID: 10458191
[TBL] [Abstract][Full Text] [Related]
10. Branch retinal vein occlusion associated with the 20210 G-to-A prothrombin variant.
Peris Martínez C; Aviñó Martínez J; Díaz-Llopis M; España Gregori E; Menezo JL; Vayá A
Eur J Ophthalmol; 2000; 10(2):177-9. PubMed ID: 10887932
[TBL] [Abstract][Full Text] [Related]
11. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.
Arsène S; Delahousse B; Regina S; Le Lez ML; Pisella PJ; Gruel Y
Thromb Haemost; 2005 Jul; 94(1):101-6. PubMed ID: 16113792
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic central retinal vein occlusion in 2 siblings with the 20210 G-->A prothrombin variant.
Peris-Martínez C; Díaz-Llopis M; Menezo JL
Arch Ophthalmol; 2002 Dec; 120(12):1752-4. PubMed ID: 12470156
[No Abstract] [Full Text] [Related]
13. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia.
Makris M; Preston FE; Beauchamp NJ; Cooper PC; Daly ME; Hampton KK; Bayliss P; Peake IR; Miller GJ
Thromb Haemost; 1997 Dec; 78(6):1426-9. PubMed ID: 9423788
[TBL] [Abstract][Full Text] [Related]
14. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
15. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
16. [Mixed retinal thrombosis in a patient carrying prothrombin gene mutation in a homozygote state].
Kling F; Macarez R; Robinet A; Kouassi FX; Colin J
J Fr Ophtalmol; 1999 Nov; 22(9):979-81. PubMed ID: 10609175
[TBL] [Abstract][Full Text] [Related]
17. Retinal vein occlusion and inherited conditions predisposing to thrombophilia.
Albisinni R; Coppola A; Loffredo M; Cerbone AM; Di Minno G; Greco GM
Thromb Haemost; 1998 Oct; 80(4):702-3. PubMed ID: 9798994
[No Abstract] [Full Text] [Related]
18. The JAK2 V617F mutation is not a cause of central retinal vein occlusion.
Hermans C; Slachmuylder V; Gala JL; Lambert C; Detrait M
Thromb Haemost; 2008 Sep; 100(3):515-6. PubMed ID: 18766271
[No Abstract] [Full Text] [Related]
19. Frequency of the 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis.
Biousse V; Conard J; Brouzes C; Horellou MH; Ameri A; Bousser MG
Stroke; 1998 Jul; 29(7):1398-400. PubMed ID: 9660394
[TBL] [Abstract][Full Text] [Related]
20. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
